current prophylact therapeutic strategy target human influenza virus include vaccine antivirus given variable rate vaccine efficacy antivirus resist alter urgent require improv disease outcome describe use his deep sequence analyze host gene express primary alveolar epithet type ii cell infect highly pathogen avian hn virus hour postinfect gene significantly upregul include cell ashes molecule webcam infect stimuli higher protein compare pr suggest key role pathogen furthermore silent endowed result reduce level proinflammatori cytokinechemokin product well replica follow studi provide revid involve clinic elev model may assist develop history 